Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes
Phase 1
Terminated
- Conditions
- Leukemia, Myelomonocytic, ChronicLeukemia, Myeloid, AcuteMyelodysplastic Syndromes
- Interventions
- First Posted Date
- 2016-07-22
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Hemavant Sciences GmbH
- Target Recruit Count
- 127
- Registration Number
- NCT02841540
- Locations
- 🇺🇸
Arizona Oncology Associates, Tucson, Arizona, United States
🇺🇸City of Hope, Irvine, California, United States
🇺🇸Rocky Mountain Cancer Center, Aurora, Colorado, United States
News
No news found